Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America

IF 6.7 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Cardiac Failure Pub Date : 2025-02-01 DOI:10.1016/j.cardfail.2024.08.046

MICHELLE WEISFELNER BLOOM MD, Co-Chair , JACQUELINE B. VO PhD, RN, MPH , JO E. RODGERS PharmD, BCPS, BCCP , ALANA M. FERRARI PharmD, BCOP , ANJU NOHRIA MD, MSc , ANITA DESWAL MD, MPH , RICHARD K. CHENG MD, MSc , MICHELLE M. KITTLESON MD, PhD , JENICA N. UPSHAW MD, MS , NICOLAS PALASKAS MD , ANNE BLAES MD MS , SHERRY-ANN BROWN MD, PhD , BONNIE KY MD, MSCE , DANIEL LENIHAN MD , MATHEW S. MAURER MD , ANECITA FADOL PhD, NP , KERRY SKURKA RN, BSN , CHRISTINE CAMBARERI PharmD, BCOP , ANA BARAC MD, PhD, (Co-Chair)

引用次数: 0

查看原文本刊更多论文

心脏肿瘤学与心力衰竭：美国心力衰竭协会科学声明的补充。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cardiac Failure 医学-心血管系统

CiteScore

7.80

自引率

8.30%

发文量

653

审稿时长

21 days

期刊介绍： Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.